2367 — Giant Biogene Holding Share News
0.000.00%
Last trade - 00:00- HK$23.99bn
- HK$15.35bn
- CNY5.52bn
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan
Brief: Giant Biogene Says Juzi Holding Purchases 560,000 Shares For HK$21.8 Million
Brief: Giant Biogene Says Unit Got Medical Device Registration Certificate From NMPA China
Brief: Giant Biogene Says Juzi Holding Purchases 500,000 Shares Of Co
Brief: Giant Biogene Says Controlling Shareholder Purchased 760,000 Shares For HK$31.9 Million
Brief: Giant Biogene Says On 24 And 25 Sept Juzi Holding Collectively Purchases 1.2 Million Shares For Hk$62.9 Million
Brief: Juzi Holding Purchases 2 Million Shares Of Giant Biogene For HK$105.6 Million
Brief: Giant Biogene Logs H1 Gross Margin 81.7%
Brief: Giant Biogene Announces Increase In Shareholding By Controlling Shareholder
Brief: Giant Biogene Says Juzi Holding Purchased 922,600 Shares At Average Price Of HK$50.62/Share
Brief: Giant Biogene Says Juzi Holding Intends To Increase Shareholding In Co With Amount No Less Than Hk$200 Million
Giant Biogene rebounds as key shareholder plans to raise stake
HK-listed Giant Biogene falls on discounted share sale
China's Giant Biogene raises about $301 million in Hong Kong share sale, term sheet shows
Brief: Giant Biogene To Raise About $250 Mln In Top Up Placement, Term Sheet Shows
Brief: Giant Biogene Holding Posts FY Gross Profit RMB 4,546.9 Million